DOCSLIB.ORG

Gene Regulatory Mechanisms in Neural Fate Decisions

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gene Regulatory Mechanisms in Neural Fate Decisions Gene regulatory mechanisms in neural fate decisions San Juan de Alicante, Spain 07 – 10 September 2017 Gene regulatory mechanisms in neural fate decisions Organizers Vijay Tiwari Magdalena Götz Yukiko Gotoh Institute of Molecular Helmholtz Zentrum University of Tokyo, Biology (IMB), Mainz, Munich and LMU, Tokyo, JAPAN GERMANY Munich, GERMANY Federico Calegari Jovica Ninkovic Victor Borrell CRTD, Helmholtz Zentrum Instituto de Neurociencias, Dresden, GERMANY München (HMGU) and LMU, CSIC & Universidad Munich, GERMANY Miguel Hernández, Alicante, SPAIN 2 · Gene regulatory mechanisms in neural fate decisions. 7 - 10 September 2017 | San Juan de Alicante, Spain Sponsors The Company of Biologists www.biologists.com 7 - 10 September 2017 | San Juan de Alicante, Spain. Gene regulatory mechanisms in neural fate decisions · 3 4 · Gene regulatory mechanisms in neural fate decisions. 7 - 10 September 2017 | San Juan de Alicante, Spain Programme Programme Day 1 – 7 September 2017 11:00 - 13:45 Registration 13:45 - 14:00 Welcome and Opening remarks Session 1. Histone Modifications Chair: Victor Borrell 14:00 - 14:30 Epigenetic priming contributes to lineage-appropriate binding of transcription factors Gunnar Schotta, Biomedical Center, Munich, Germany 14:30 - 15:00 Mechanisms regulating synapse-specific gene expression by HDAC2 in neurons Li-Huei Tsai, Massachusetts Institute of Technology, Cambridge, USA 15:00 - 15:30 Regulation of embryonic and adult neural stem cell fate Yukiko Gotoh, University of Tokyo, Tokyo, Japan 15:30 - 16:00 Epigenetic regulation of neuronal development and function Vijay Tiwari, Institute of Molecular Biology (IMB), Mainz, Germany 16:00 - 16:30 Short Talks: Kdm5c prevents spurious transcription, silences germ line genes and modulates transcription of regulatory ncRNAs Marilyn Scandaglia, Universidad Miguel Hernández-CSIC, Alicante, Spain DOT1L and H3K79 methylation establish transmittable layer identity in progenitors of the cerebral cortex Tanja Vogel, Institute for Anatomy and Cell Biology, Department of Molecular Embryology, Albert-Ludwigs-University Freiburg, Germany 16:30 - 17:00 Coffe break (Venue’s Science Lounge) and informal discussion 6 · Gene regulatory mechanisms in neural fate decisions. 7 - 10 September 2017 | San Juan de Alicante, Spain Session 2. Modifications of DNA Chair: Magdalena Götz 17:30 - 18:00 Epitranscriptomic mechanism regulating mammalian cortical neurogenesis Hongjun Song, University of Pennsylvania, USA 18:00 - 18:30 A role for endogenous retroviruses in human brain evolution Johan Jakobson, Wallenberg Neuroscience Center, Lund University, Lund, Sweden 18:30 - 19:00 Gene regulation in chromatin Dirk Schübeler, FMI, Basel, Switzerland 19:00 - 19:30 The Chromatin deacetylase SIRT6 drives early cell-fate decisions in embryonic development Raul Mostoslawsky, The Massachusetts General Hospital Cancer Cen- ter, Harvard Medical School, Boston, MA USA 19:30 - 20:00 Transposable elements, their polydactyl controllers and the uniqueness of the human brain Didier Trono, EPFL, Geneva, Switzerland 20:00 - 20:30 Epigenetic control of neural stem cells during corticogenesis Federico Calegari, CRTD, Dresden, Germany 20:30 - 22:00 Dinner and informal discussions Day 2 – 8 September 2017 Session 3. Non-coding Genome Chair: Francois Guillemot 09:00 - 09:30 Long non-coding RNAs (lncRNAs) in neural development Dan Lim, UCSF, San Francisco, USA 09:30 - 10:00 Molecular basis of synaptic plasticity Michael Kiebler, Ludwig-Maximilians-University, Munich, Germany 7 - 10 September 2017 | San Juan de Alicante, Spain. Gene regulatory mechanisms in neural fate decisions · 7 10:00 - 10:30 Systematic identification of regulators of an alternative splicing regulatory network underlying nervous system development and autism spectrum disorders Benjamin J. Blencowe, University of Toronto, Toronto, Canada 10:30 - 11:00 Bimodal gene regulation of neural progenitors by Nup153 in cooperation with Sox2 Rusty Gage, Salk Institute for Biological Studies, La Jolla, USA 11:00 - 11:30 Short Talks: miRNA-independent functions of Dgcr8 control mouse corticogene- sis: implications for neocortex expansion Davide De Pietri Tonelli, Neurobiology of microRNA lab, Istituto Italiano di Tecnologia, Genoa, Italy Transcriptional and chromatin accessibility dynamics during status epilepticus J. Fernàndez-Albert, Instituto de Neurociencias de Alicante (Univer- sidad Miguel Hernández-CSIC), Alicante, Spain 11:30 - 12:00 Coffe break (Venue’s Science Lounge) and informal discussion Non-coding Genome Continues 12:00 - 12:30 L1 retrotransposition in the mammalian brain Geoffrey J. Faulkner, University of Queensland, Brisbane, Australia 12:30 - 13:00 Quantitative and dynamic analysis of neurogenesis with single cell resolution at the tissue level Nancy Papalopulu, The University of Manchester, Manchester, UK 13:00 - 13:30 Chromatin regulation of cerebellar granule neuron maturation Anne West, Duke University, Durham, USA 13:30 - 14:00 Choroid Plexus releases miR-204 regulating the number of neural stem cells in the subependymal zone Jovica Ninkovic, Helmholtz Zentrum München and LMU, Munich, Germany 14:00 - 15:00 Lunch (Venue’s Social Lounge) and informal discussion 15:00 - 17:30 Poster Session I – Presenting odd numbers 16:30 - 17:30 Coffee in parallel to poster sessions 8 · Gene regulatory mechanisms in neural fate decisions. 7 - 10 September 2017 | San Juan de Alicante, Spain Session 4. Chromatin remodeling Chair: Vijay Tiwari 17:30 - 18:00 Shaping the Neuronal Epigenetic Landscape in development and disease by neuron-specific nBAF Complexes Jerry Crabtree, Stanford University, San Francisco, USA 18:00 - 18:30 Chromatin as a hub integrating environmental signals and fate decisions in adult neural stem cells Ana Martin Villalba, DKFZ Heildeberg, Germany 18:30 - 19:00 Role of the chromatin remodeller CHD7 in neurogenesis and brain diseases Haikun Liu, DKFZ Heidelberg, Germany EMBO Young Investigator Lecture 19:00 - 19:30 Proliferation control, temporal identity and cell immortalization in Dro- sophila neural stem cell lineages Jurgen Knoblich, IMBA, Vienna, Austria 19:30 - 20:00 Short Talks: Epigenetic and genetic programming of growth by modulating Zdbf2 dosage in the brain Juliane Glaser, Institut Curie, PSL Research University, INSERM, CNRS, Paris, France The POU homeobox gene BRN3A maintains the identity of multiple neu- ron types throughout the CNS Esther Serrano-Saiz, Columbia University of New York 20:00 - 22:00 Dinner (Venue’s Social Lounge) and informal discussion Day 3 – 9 September 2017 Session 5. Transcription Factors Chair: Federico Calegari 09:00 - 09:30 Post-translational regulation of stem cell quiescence and activity in the adult brain Francois Guillemot, The Francis Crick Institute, London, UK 7 - 10 September 2017 | San Juan de Alicante, Spain. Gene regulatory mechanisms in neural fate decisions · 9 09:30 - 10:00 What does the FOX say: Gene regulatory networks in the developing neocortex Soo-Kyung Lee, Oregon Health & Science University, Portland, USA 10:00 - 10:30 Transcriptional dynamics in cortical development Verdon Taylor, University of Basel, Basel, Switzerland 10:30 - 11:00 Uncovering spatiotemporal windows in cortical development Shubha Tole, Tata Institute of Fundamental Research, India 11:00 - 11:30 Short Talks: Sox2 is required for global functional chromatin connectivity in brain-derived neural stem cells Silvia Nicolis, Department of Biotechnology and Biosciences, University Milano-Bicocca, Milano, Italy Identifying Novel Transcriptional Regulators of Neurogenesis Angela Garding, Institute of Molecular Biology (IMB), Mainz, Germany 11:30 - 12:00 Coffe break (Venue’s Science Lounge) and informal discussion Transcription Factors continues 12:00 - 12:30 Decoding the gene regulatory logic of neuronal cell type specification in C. elegans Oliver Hobert, Columbia University, New York, USA 12:30 - 13:00 Dynamic transcriptional control of neural stem cells Ryoichiro Kageyama, Kyoto University, Kyoto, Japan 13:00 - 13:30 Epigenetic regulation of aging neural stem cells Anne Brunet, Standford University, San Francisco, USA 13:30 - 14:30 Lunch (Venue’s Social Lounge) and informal discussion 14:30 - 17:30 Poster Session II – Presenting even numbers 16:30 - 17:30 Coffee in parallel to poster sessions 10 · Gene regulatory mechanisms in neural fate decisions. 7 - 10 September 2017 | San Juan de Alicante, Spain Session 6. Distal gene regulation and nuclear organization Chair: Li-Huei Tsai 17:30 - 18:00 Chromosomal enhancer nuclear syntax: ligand-dependent 3D redistribu- tion of “First Tier” enhancers generate mega-enhancers that associate with subnuclear phase-separated structures to dictate enhancer robustness Michael Rosenfeld, University of California, San Francisco, USA 18:00 - 18:30 Gene regulation in development and evolution of the human cerebral cortex Christopher A. Walsh, Boston Children’s Hospital, Boston, USA 18:30 - 19:00 Genome Architecture Mapping: discovering chromatin contacts in rare cell types Ana Pombo, MDC, Berlin, Germany 19:00 - 19:30 Short Talks: Gene network governing the commitment of radial glial cells to ependymal lineage Stavros Taraviras, Department of Physiology, Medical School, University of Patras, Greece Mechanisms of epigenetic priming that underpin changes in neuronal identity Philipp Mews, Icahn School of Medicine at Mount Sinai, New York, USA 20:00 - 22:00 Dinner (Venue’s Social Lounge) and informal discussion Day 4 – 10 September 2017 Session 7. Single cell transcriptome and epigenome
Load more

Recommended publications
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Prospective Isolation of NKX2-1–Expressing Human Lung Progenitors Derived from Pluripotent Stem Cells
    The Journal of Clinical Investigation RESEARCH ARTICLE Prospective isolation of NKX2-1–expressing human lung progenitors derived from pluripotent stem cells Finn Hawkins,1,2 Philipp Kramer,3 Anjali Jacob,1,2 Ian Driver,4 Dylan C. Thomas,1 Katherine B. McCauley,1,2 Nicholas Skvir,1 Ana M. Crane,3 Anita A. Kurmann,1,5 Anthony N. Hollenberg,5 Sinead Nguyen,1 Brandon G. Wong,6 Ahmad S. Khalil,6,7 Sarah X.L. Huang,3,8 Susan Guttentag,9 Jason R. Rock,4 John M. Shannon,10 Brian R. Davis,3 and Darrell N. Kotton1,2 2 1Center for Regenerative Medicine, and The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA. 3Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, Texas, USA. 4Department of Anatomy, UCSF, San Francisco, California, USA. 5Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. 6Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts, USA. 7Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA. 8Columbia Center for Translational Immunology & Columbia Center for Human Development, Columbia University Medical Center, New York, New York, USA. 9Department of Pediatrics, Monroe Carell Jr. Children’s Hospital, Vanderbilt University, Nashville, Tennessee, USA. 10Division of Pulmonary Biology, Cincinnati Children’s Hospital, Cincinnati, Ohio, USA. It has been postulated that during human fetal development, all cells of the lung epithelium derive from embryonic, endodermal, NK2 homeobox 1–expressing (NKX2-1+) precursor cells.
    [Show full text]
  • High-Mobility Group A1 Proteins May Be Involved in Estrogen Receptor Status of Breast Cancer
    3786 Editorial Commentary High-mobility group A1 proteins may be involved in estrogen receptor status of breast cancer Yoshihiro Harada, Kenji Ohe Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Fukuoka University, Jonan-ku, Fukuoka, Japan Correspondence to: Kenji Ohe. Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Fukuoka University, Building 17, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-180, Japan. Email: [email protected]. Provenance and Peer Review: This article was commissioned by the editorial office, Translational Cancer Research. The article did not undergo external peer review. Comment on: Gorbounov M, Carleton NM, Asch-Kendrick RJ, et al. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer. Breast Cancer Res Treat 2020;179:25-35. Submitted Apr 27, 2020. Accepted for publication May 13, 2020. doi: 10.21037/tcr-20-1921 View this article at: http://dx.doi.org/10.21037/tcr-20-1921 The three types of breast cancer HMGA1 proteins: old and new proteins in breast cancer Breast cancer is one of the most common of cancers in woman. About 316,700 new cases were diagnosed as breast HMGA1 (previously called HMGI/Y) is a member of the cancer in US woman in 2019 and 41,760 were predicted to high-mobility group (HMG) proteins that were found from die from it (1). Breast cancer has a characteristic of therapy- their high mobility characteristics during polyacrylamide targeting receptors: hormone receptors (HR) that are electrophoresis of non-histone chromatin-associated estrogen receptor [ER: human ERα protein (NCBI protein proteins (3).
    [Show full text]
  • Download Program Guide
    2011 C. elegans Meeting Organizing Committee Co-chairs: Oliver Hobert Columbia University Meera Sundaram University of Pennsylvania Organizing Committee: Raffi Aroian University of California, San Diego Ikue Mori Nagoya University Jean-Louis Bessereau INSERM Benjamin Podbilewicz Technion Israel Institute of Keith Blackwell Harvard Medical School Technology Andrew Chisholm University of California, San Diego Valerie Reinke Yale University Barbara Conradt Dartmouth Medical School Janet Richmond University of Illinois, Chicago Marie Anne Felix CNRS-Institut Jacques Monod Ann Rougvie University of Minnesota David Greenstein University of Minnesota Shai Shaham Rockefeller University Alla Grishok Columbia University Ahna Skop University of Wisconsin, Madison Craig Hunter Harvard University Ralf Sommer Max-Planck Institute for Bill Kelly Emory University Developmental Biology, Tuebingen Ed Kipreos University of Georgia Asako Sugimoto RIKEN, Kobe Todd Lamitina University of Pennsylvania Heidi Tissenbaum University of Massachusetts Chris Li City College of New York Medical School Sponsored by The Genetics Society of America 9650 Rockville Pike, Bethesda, MD 20814-3998 telephone: (301) 634-7300 fax: (301) 634-7079 e-mail: [email protected] Web site: http:/www.genetics-gsa.org Front cover design courtesy of Ahna Skop 1 Table of Contents Schedule of All Events.....................................................................................................................4 Maps University of California, Los Angeles, Campus .....................................................................7
    [Show full text]
  • The Novel Membrane-Bound Proteins MFSD1 and MFSD3 Are Putative SLC Transporters Affected by Altered Nutrient Intake
    J Mol Neurosci DOI 10.1007/s12031-016-0867-8 The Novel Membrane-Bound Proteins MFSD1 and MFSD3 are Putative SLC Transporters Affected by Altered Nutrient Intake Emelie Perland1,2 & Sofie V. Hellsten2 & Emilia Lekholm2 & Mikaela M. Eriksson2 & Vasiliki Arapi2 & Robert Fredriksson2 Received: 29 August 2016 /Accepted: 21 November 2016 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Membrane-bound solute carriers (SLCs) are essen- Introduction tial as they maintain several physiological functions, such as nutrient uptake, ion transport and waste removal. The SLC Membrane-bound transporters are physiologically important family comprise about 400 transporters, and we have identi- as they keep the homeostasis of soluble molecules within cel- fied two new putative family members, major facilitator su- lular compartments, and it is crucial to study their basic his- perfamily domain containing 1 (MFSD1) and 3 (MFSD3). tology and function to understand the human body. The solute They cluster phylogenetically with SLCs of MFS type, and carrier (SLC) superfamily is the largest group of membrane- both proteins are conserved in chordates, while MFSD1 is also bound transporters in human and it includes 395 members, found in fruit fly. Based on homology modelling, we predict divided in 52 families (Hediger et al. 2004). SLCs utilize 12 transmembrane regions, a common feature for MFS trans- ATP-independent mechanisms to move nutrients, ions, drugs porters. The genes are expressed in abundance in mice, with and waste over lipid membranes, and SLC deficiencies are specific protein staining along the plasma membrane in neu- associated with several human diseases (Hediger et al.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Exploring Nsr100/SRRM4 As a Therapeutic Target for Autism Spectrum Disorder in Mice
    Exploring nSR100/SRRM4 as a therapeutic target for autism spectrum disorder in mice by Juli Wang A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Molecular Genetics University of Toronto © Copyright by Juli Wang, 2019 I Exploring nSR100/SRRM4 as a Therapeutic Target for ASD in Mice Juli Wang Master of Science Department of Molecular Genetics University of Toronto 2019 Abstract Misregulation of nSR100 and its target microexons are common in a large proportion of ASD patients and cause ASD-associated features in mice. This thesis explores nSR100 and its target splicing program as a potential therapeutic target using a conditional knockout allele, nSR100GT. I show that nSR100 protein is effectively depleted in the cortical regions of nSR100GT mutant mice at E17.5, E18.5, and P2 stages, which correlates with phenotypes overlapping with all core behavioral domains of ASD. I show that tamoxifen-mediated rescue in prenatal nSR100GT animals restores nSR100 protein and microexon inclusion levels comparable to those observed in wildtype mice. Collectively my thesis research shows that the nSR100GT mouse strain holds the promise for examining phenotypic effects of nSR100 reactivation in ASD-like mice at different developmental stages, and complimentary models are also to be considered for investigating the therapeutic potential of targeting nSR100 in the context of ASD. II Acknowledgments I wholeheartedly thank for the tremendous support and educational experiences I have received from my mentors,
    [Show full text]
  • Primary Driver Mutations in GTF2I Specific to the Development Of
    cancers Article Primary Driver Mutations in GTF2I Specific to the Development of Thymomas Rumi Higuchi 1, Taichiro Goto 1,* , Yosuke Hirotsu 2 , Yujiro Yokoyama 1, Takahiro Nakagomi 1, Sotaro Otake 1, Kenji Amemiya 2,3, Toshio Oyama 3, Hitoshi Mochizuki 2 and Masao Omata 2,4 1 Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Yamanashi 400-8506, Japan; [email protected] (R.H.); [email protected] (Y.Y.); [email protected] (T.N.); [email protected] (S.O.) 2 Genome Analysis Center, Yamanashi Central Hospital, Yamanashi 400-8506, Japan; [email protected] (Y.H.); [email protected] (K.A.); [email protected] (H.M.); [email protected] (M.O.) 3 Department of Pathology, Yamanashi Central Hospital, Yamanashi 400-8506, Japan; [email protected] 4 Department of Gastroenterology, The University of Tokyo Hospital, Tokyo 113-8655, Japan * Correspondence: [email protected]; Tel.: +81-55-253-7111 Received: 16 June 2020; Accepted: 22 July 2020; Published: 24 July 2020 Abstract: Thymomas are rare mediastinal tumors that are difficult to treat and pose a major public health concern. Identifying mutations in target genes is vital for the development of novel therapeutic strategies. Type A thymomas possess a missense mutation in GTF2I (chromosome 7 c.74146970T>A) with high frequency. However, the molecular pathways underlying the tumorigenesis of other thymomas remain to be elucidated. We aimed to detect this missense mutation in GTF2I in other thymoma subtypes (types B). This study involved 22 patients who underwent surgery for thymomas between January 2014 and August 2019.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, IRVINE Combinatorial Regulation By
    UNIVERSITY OF CALIFORNIA, IRVINE Combinatorial regulation by maternal transcription factors during activation of the endoderm gene regulatory network DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biological Sciences by Kitt D. Paraiso Dissertation Committee: Professor Ken W.Y. Cho, Chair Associate Professor Olivier Cinquin Professor Thomas Schilling 2018 Chapter 4 © 2017 Elsevier Ltd. © 2018 Kitt D. Paraiso DEDICATION To the incredibly intelligent and talented people, who in one way or another, helped complete this thesis. ii TABLE OF CONTENTS Page LIST OF FIGURES vii LIST OF TABLES ix LIST OF ABBREVIATIONS X ACKNOWLEDGEMENTS xi CURRICULUM VITAE xii ABSTRACT OF THE DISSERTATION xiv CHAPTER 1: Maternal transcription factors during early endoderm formation in 1 Xenopus Transcription factors co-regulate in a cell type-specific manner 2 Otx1 is expressed in a variety of cell lineages 4 Maternal otx1 in the endodermal conteXt 5 Establishment of enhancers by maternal transcription factors 9 Uncovering the endodermal gene regulatory network 12 Zygotic genome activation and temporal control of gene eXpression 14 The role of maternal transcription factors in early development 18 References 19 CHAPTER 2: Assembly of maternal transcription factors initiates the emergence 26 of tissue-specific zygotic cis-regulatory regions Introduction 28 Identification of maternal vegetally-localized transcription factors 31 Vegt and OtX1 combinatorially regulate the endodermal 33 transcriptome iii
    [Show full text]
  • An Ontogenetic Switch Drives the Positive and Negative Selection of B Cells
    An ontogenetic switch drives the positive and negative selection of B cells Xijin Xua, Mukta Deobagkar-Lelea, Katherine R. Bulla, Tanya L. Crockforda, Adam J. Meadb, Adam P. Cribbsc, David Simsc, Consuelo Anzilottia, and Richard J. Cornalla,1 aMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom; bMedical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom; and cMedical Research Council, Weatherall Institute of Molecular Medicine, Centre for Computational Biology, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom Edited by Michael Reth, University of Freiburg, Freiburg, Germany, and approved January 6, 2020 (received for review September 3, 2019) + Developing B cells can be positively or negatively selected by self- BM HSCs increased CD5 B-1a B cell development (15), while antigens, but the mechanisms that determine these outcomes are expression of let-7b in FL pro-B cells blocked the development of incompletely understood. Here, we show that a B cell intrinsic B-1 B cells (17). These findings support the notion of hard-wired switch between positive and negative selection during ontogeny differences during ontogeny, but possibly downstream of the HSC is determined by a change from Lin28b to let-7 gene expression. commitment stage. Ectopic expression of a Lin28b transgene in murine B cells restored Several lines of evidence also suggest that B-1 B cells can un- the positive selection of autoreactive B-1 B cells by self-antigen in dergo positive selection, which is linked to their B cell receptor adult bone marrow.
    [Show full text]
  • X Chromosome Dosage of Histone Demethylase KDM5C Determines Sex Differences in Adiposity
    X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity Jenny C. Link, … , Arthur P. Arnold, Karen Reue J Clin Invest. 2020. https://doi.org/10.1172/JCI140223. Research Article Genetics Metabolism Graphical abstract Find the latest version: https://jci.me/140223/pdf The Journal of Clinical Investigation RESEARCH ARTICLE X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity Jenny C. Link,1 Carrie B. Wiese,2 Xuqi Chen,3 Rozeta Avetisyan,2 Emilio Ronquillo,2 Feiyang Ma,4 Xiuqing Guo,5 Jie Yao,5 Matthew Allison,6 Yii-Der Ida Chen,5 Jerome I. Rotter,5 Julia S. El -Sayed Moustafa,7 Kerrin S. Small,7 Shigeki Iwase,8 Matteo Pellegrini,4 Laurent Vergnes,2 Arthur P. Arnold,3 and Karen Reue1,2 1Molecular Biology Institute, 2Human Genetics, David Geffen School of Medicine, 3Integrative Biology and Physiology, and 4Molecular, Cellular and Developmental Biology, UCLA, Los Angeles, California, USA. 5Institute for Translational Genomics and Population Sciences, Department of Pediatrics, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA. 6Division of Preventive Medicine, School of Medicine, UCSD, San Diego, California, USA. 7Department of Twin Research and Genetic Epidemiology, King’s College London, London, United Kingdom. 8Human Genetics, Medical School, University of Michigan, Ann Arbor, Michigan, USA. Males and females differ in body composition and fat distribution. Using a mouse model that segregates gonadal sex (ovaries and testes) from chromosomal sex (XX and XY), we showed that XX chromosome complement in combination with a high-fat diet led to enhanced weight gain in the presence of male or female gonads.
    [Show full text]
  • Whole Genome Comparative Genomic Hybridization of Ewing Sarcoma Indicates Cytoskeleton, Migration and Protein Trafficking †
    Proceedings Whole Genome Comparative Genomic Hybridization of Ewing Sarcoma Indicates Cytoskeleton, Migration and Protein Trafficking † Burçin Baran 1, Safiye Aktaş 1,*, Hülya Tosun 1,2, Gülden Diniz 1,2, Yasemin Çakır 1,2, Tekincan Çağrı Aktaş 1, Zekiye Altun 1 and Nur Olgun 1 1 Institute of Oncology, Dokuz Eylul University, Izmir 35340, Turkey; [email protected] (B.B.); [email protected] (H.T.); [email protected] (G.D.); [email protected] (Y.Ç.); [email protected] (T.Ç.A.); [email protected] (Z.A.); [email protected] (N.O.) 2 Dr.Behcet Uz Children’s Research Hospital, Izmir 35210, Turkey * Correspondence: [email protected] † Presented at the 2nd International Cell Death Research Congress, Izmir, Turkey, 1–4 November 2018. Published: 5 December 2018 Abstract: Ewing sarcoma is a bone and soft tissue tumor either neuroectodermal or mesenchymal originated and affecting children and adolescents. In the present study, we aimed to find out prognostic and predictive biomarkers for Ewing sarcoma. Hence, we examined the copy number alterations (and related possible genes) among ten Ewing sarcoma patient samples and possible associations with the clinical outcome. DNA extraction from formalin fixed paraffin embedded archive tissues was performed. Whole genome Comparative Genomic Hybridization (CGH) was performed by NimbleGen and recorded as single Panel Rainbow through chromosomes 1–22, X and Y. Data was interpreted by SignalMap software and genetic regions matching the deletion or amplification loci were recorded. The mean age of the patients was 8.6 years. Three of the cases were male, while seven were female. According to CGH analysis, the most common DNA copy number alterations were found in SLIT-ROBO Rho GTPase activating protein (srGAP2), RANBP2 like GRIP domain (RGPD5), nephrocystin 1 (NPHP1), GTF2I repeat domain containing 2 (GTF2IRD2), pyridoxal dependent decarboxylase domain containing 1 (PXDC1), which were found down- regulated among 7 of 10 patients.
    [Show full text]